Charles Schwab’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.4M | Buy |
933,204
+219,665
| +31% | +$10.7M | 0.01% | 1164 |
|
|
2025
Q1 | $24.3M | Sell |
713,539
-9,493
| -1% | -$323K | ﹤0.01% | 1528 |
|
|
2024
Q4 | $28.5M | Sell |
723,032
-1,209
| -0.2% | -$47.6K | 0.01% | 1492 |
|
|
2024
Q3 | $34M | Buy |
724,241
+6,635
| +0.9% | +$312K | 0.01% | 1363 |
|
|
2024
Q2 | $38.8M | Buy |
717,606
+48,414
| +7% | +$2.61M | 0.01% | 1248 |
|
|
2024
Q1 | $45.6M | Buy |
669,192
+16,169
| +2% | +$1.1M | 0.01% | 1108 |
|
|
2023
Q4 | $40.9M | Buy |
653,023
+15,085
| +2% | +$944K | 0.01% | 1133 |
|
|
2023
Q3 | $29M | Sell |
637,938
-8,773
| -1% | -$398K | 0.01% | 1249 |
|
|
2023
Q2 | $36.3M | Buy |
646,711
+5,934
| +0.9% | +$333K | 0.01% | 1095 |
|
|
2023
Q1 | $29M | Sell |
640,777
-317
| -0% | -$14.3K | 0.01% | 1193 |
|
|
2022
Q4 | $26.1M | Buy |
641,094
+18,976
| +3% | +$771K | 0.01% | 1247 |
|
|
2022
Q3 | $40.7M | Buy |
622,118
+273,995
| +79% | +$17.9M | 0.01% | 883 |
|
|
2022
Q2 | $21.2M | Sell |
348,123
-6,680
| -2% | -$406K | 0.01% | 1368 |
|
|
2022
Q1 | $22.3M | Buy |
+354,803
| New | +$22.3M | 0.01% | 1459 |
|